-
Blood Disorder Drug Maker Acquired in $11.6B Deal
The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders.
-
Infographic – Artificial Intelligence in Smartphones
Our friends at Statista recently documented the leading ways artificial intelligence is used in smartphones, which is this weekend’s infographic.
-
Institute, Company Partner on Implanted Neuro Device
A research center in Switzerland and medical engineering company in Germany are developing an implanted device to measure signals and treat disorders affecting the brain.
-
Stem Cells Created with Gene Editing
A research lab in San Francisco devised a simpler process for creating stem cells from skin cells in mice with the gene editing technique Crispr.
-
The Importance Of Market Research
Regularly conducting market research is very important to any business, regardless what it is that you do. It’s a way of keeping up to date with any important changes that could potentially affect your company.
-
Limited Industry Progress Seen on Microbial Resistance
A pharmaceutical industry coalition documents some advances after 2 years in developing better products and practices against antimicrobial resistance, but progress is limited and uneven.
-
Technique Developed for High-Speed Antibody Screening
A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses.
-
Little Data to Support Wearable Device Health Benefits
A review of published research since 2000 shows little evidence to support claims of beneficial health outcomes from the use of wearable devices like smart watches or wristbands, at least not yet.
-
Small Business Grant Advances Drug Safety Test System
An award from National Institutes of Health is advancing a technology for testing the safety of drugs with heart muscle cells derived from stem cells before the drugs are tested on humans.
-
FDA to Release More Accessible Clinical Trial Data
The U.S. Food and Drug Administration plans to make available in a more user-friendly format details from clinical trials of new drugs approved by the agency.